Trials / Completed
CompletedNCT01326611
Efficacy of Clarithromycin Treatment in Prevention of Chronic Lung Disease in Premature Infants
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 273 (actual)
- Sponsor
- Zekai Tahir Burak Women's Health Research and Education Hospital · Academic / Other
- Sex
- All
- Age
- 1 Hour – 2 Days
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of clarithromycin in eradication of ureaplasma urealyticum and prevention of chronic lung disease in premature infants with birthweight \< 1250 g and have ureaplasma urealyticum colonization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clarithromycin | |
| DRUG | Dextrose |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2010-09-01
- Completion
- 2010-12-01
- First posted
- 2011-03-31
- Last updated
- 2011-03-31
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01326611. Inclusion in this directory is not an endorsement.